	自己資本および準備金		日付
AbbVie	USD -6.66B	3.39B	2026-03
Amgen	USD 9.19B	532M	2026-03
Anika Therapeutics	USD 133.9M	9.56M	2026-03
Arrowhead Research	USD 613.98M	45.56M	2026-03
AstraZeneca	USD 47.33B	1.33B	2026-03
BioCryst Pharmaceuticals	USD -553.84M	434.69M	2026-03
Biogen	USD 18.65B	394.9M	2026-03
Bristol-Myers Squibb	USD 20.07B	1.6B	2026-03
Enanta Pharmaceuticals	USD 126.59M	61.87M	2025-12
Gilead Sciences	USD 23.52B	897M	2026-03
GlaxoSmithKline	GBP 17.42B	1.05B	2026-03
Halozyme Therapeutics	USD 219.64M	170.82M	2026-03
Heron Therapeutics	USD 9.14M	4.15M	2026-03
Immunic	USD 151.23M	157.91M	2026-03
Incyte	USD 5.62B	455.37M	2026-03
Insmed	USD 704.85M	34.12M	2026-03
Ionis Pharmaceuticals	USD 491.41M	2.32M	2026-03
J&J	USD 84.97B	3.78B	2026-06
Karyopharm Therapeutics	USD -292.93M	23.67M	2025-12
Ligand Pharmaceuticals	USD 997.32M	19.89M	2026-03
Merck	USD 45.88B	6.73B	2026-03
Neurocrine Biosciences	USD 3.41B	154.3M	2026-03
Novartis	USD 38.93B	7.2B	2026-03
Novavax	USD -144.76M	17.01M	2026-03
Pfizer	USD 90.1B	3.63B	2026-03
PTC Therapeutics	USD -180.46M	24.85M	2026-03
Roche Holding	CHF 32.69B	1.11B	2026-06
Sarepta Therapeutics	USD 1.51B	364.48M	2026-03
Vertex Pharmaceuticals	USD 19.36B	696.1M	2026-03